Diabetic Medicine

雜志介紹

Diabetic Medicine雜志介紹

《Diabetic Medicine》是一本以English為主的未開放獲取國際優秀期刊，中文名稱糖尿病醫學，本刊主要出版、報道醫學-ENDOCRINOLOGY & METABOLISM領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為3.2，最新CiteScore 指數為7.2。

本刊近期中國學者發表的論文主要有：

• MicroRNA-7a-5p ameliorates diabetic peripheral neuropathy by regulating VDAC1/JNK/c-JUN pathway

  Author: Jiao, Yang; Zhang, Yue-Hua; Wang, Chun-Yan; Yu, Yang; Li, Yi-Ze; Cui, Wei; Li, Qing; Yu, Yong-Hao

• Prevalence and risk factors of cognitive frailty in community-dwelling older adults with diabetes: A systematic review and meta-analysis

  Author: Lyu, Qiong; Guan, Chi-Xun; Kong, Ling-Na; Zhu, Jia-Lu

• Lysine demethylase KDM5B down-regulates SIRT3-mediated mitochondrial glucose and lipid metabolism in diabetic neuropathy

  Author: Jiao, Yang; Li, Yi-Ze; Zhang, Yue-Hua; Cui, Wei; Li, Qing; Xie, Ke-Liang; Yu, Yang; Yu, Yong-Hao

• The vicious circle of UHRF1 down-regulation and KEAP1/NRF2/HO-1 pathway impairment promotes oxidative stress-induced endothelial cell apoptosis in diabetes

  Author: Guo, Zi; Wan, Xinxing; Luo, Yufang; Liang, Fang; Jiang, Siwei; Yuan, Xiuhong; Mo, Zhaohui

英文介紹

Diabetic Medicine雜志英文介紹

Diabetic Medicine, the official journal of Diabetes UK, is published monthly simultaneously, in print and online editions.

The journal publishes a range of key information on all clinical aspects of diabetes mellitus, ranging from human genetic studies through clinical physiology and trials to diabetes epidemiology. We do not publish original animal or cell culture studies unless they are part of a study of clinical diabetes involving humans. Categories of publication include research articles, reviews, editorials, commentaries, and correspondence. All material is peer-reviewed.

We aim to disseminate knowledge about diabetes research with the goal of improving the management of people with diabetes. The journal therefore seeks to provide a forum for the exchange of ideas between clinicians and researchers worldwide. Topics covered are of importance to all healthcare professionals working with people with diabetes, whether in primary care or specialist services.

Surplus generated from the sale of Diabetic Medicine is used by Diabetes UK to know diabetes better and fight diabetes more effectively on behalf of all people affected by and at risk of diabetes as well as their families and carers.”